PT-141 10mg
Synedica PT-141 is a high-quality research-grade peptide developed for controlled laboratory studies related to melanocortin receptor pathways, wellness research, and advanced formulation development.
PT-141 is commonly explored in R&D settings focused on signaling pathways, peptide stability, and receptor-related research models. Its profile makes it suitable for controlled studies requiring precision, consistency, and high-quality formulation evaluation.
This product is intended exclusively for laboratory research and development applications.
Important Notice
All products are produced exclusively for controlled laboratory research and development applications.
Not for human or animal consumption.
Suitable R&D Applications
Stability Testing
Thermal, enzymatic, and oxidative degradation studies
Shelf-life evaluation & formulation robustness
Formulation Development
Enhances solubility, bioavailability, and structural integrity
Tailored for injectable, topical, and research-grade use
Excipient Compatibility Testing
Evaluates interactions between peptides & inactive components
Ensures safety, stability, and performance
Protease Resistance Evaluation
Assesses susceptibility to enzymatic breakdown
Supports development of more durable peptide products
Encapsulation & Carrier Systems
Liposomes, microspheres, and other delivery vehicles
Protects peptides & enables controlled release
Administration Route Assessment
Optimized for:
Parenteral delivery (injectables)
Dermal absorption (cosmetic/topical)
In vitro research applications